Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/Sales ratio high or low?
The EV/Sales ratio of 14.94x is 95% above its estimated 5-year average of 7.67x, near the low end of its estimated 5-year range (0.48x–231.91x).
As of 2026-10-06T15:40:57.015Z. 495.91% above its estimated 12-month average of 2.51x.
Calculation as of: 2026-10-06T15:40:57.015Z.
Quote observation: 2026-10-06T15:39:33.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: c84a17f2c5c981e3cafbb97a54cdccede593a8f239875ee545639e7176ba2e68
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
14.94x
EV/SALES RATIO AVG TTM
2.51x
EV/SALES RATIO AVG 3Y
3.30x
EV/SALES RATIO AVG 5Y
7.67x
EV/SALES RATIO AVG 10Y
N/A
EV/SALES RATIO AVG 15Y
N/A
EV/SALES RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+495.91%
CURRENT VS 3Y AVG
+352.64%
CURRENT VS 5Y AVG
+94.75%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.20x
median of 447 covered companies
CURRENT VS SECTOR MEDIAN
+255.71%
vs the sector median at left
Atara Biotherapeutics, Inc.
Market Cap
$85.87M
EV/Sales Ratio
14.94x
TTM Avg
2.51x
3Y Avg
3.30x
5Y Avg
7.67x
Market Cap
$85.01M
EV/Sales Ratio
N/A
TTM Avg
9472.81x
3Y Avg
14921.28x
5Y Avg
40247.63x
Market Cap
$85.01M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$85.16M
EV/Sales Ratio
33.68x
TTM Avg
52.52x
3Y Avg
427.47x
5Y Avg
706.12x
Market Cap
$85.17M
EV/Sales Ratio
150.45x
TTM Avg
202.08x
3Y Avg
199.51x
5Y Avg
216.66x
Market Cap
$83.18M
EV/Sales Ratio
62.89x
TTM Avg
119.91x
3Y Avg
82.00x
5Y Avg
251.31x
Market Cap
$83.04M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Atara Biotherapeutics, Inc. (ATRA) | $85.87M | 14.94x | 2.51x | 3.30x | 7.67x |
| ProMIS Neurosciences, Inc. (PMN)vs › | $85.01M | N/A | 9472.81x | 14921.28x | 40247.63x |
| Cognition Therapeutics, Inc. (CGTX)vs › | $85.01M | N/A | N/A | N/A | N/A |
| Humacyte, Inc. (HUMA)vs › | $85.16M | 33.68x | 52.52x | 427.47x | 706.12x |
| Cardiff Oncology, Inc. (CRDF)vs › | $85.17M | 150.45x | 202.08x | 199.51x | 216.66x |
| MediciNova, Inc. (MNOV)vs › | $83.18M | 62.89x | 119.91x | 82.00x | 251.31x |
| CareCloud, Inc. (CCLD)vs › | $86.69M | 0.99x | 1.01x | 0.60x | 0.55x |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $83.04M | N/A | N/A | N/A | N/A |
| LENSAR Inc (LNSR)vs › | $82.41M | 1.18x | 1.93x | 1.60x | 1.28x |
| Nutriband Inc. (NTRB)vs › | $81.57M | 48.43x | 23.70x | 23.39x | 21.39x |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/SALES RATIO |
|---|---|
| 2026-10-05 | 23.89x |
| 2026-10-02 | 24.08x |
| 2026-10-01 | 21.61x |
| 2026-09-30 | 21.70x |
| 2026-09-29 | 20.61x |
| 2026-09-28 | 21.39x |
| 2026-09-25 | 22.46x |
| 2026-09-24 | 21.80x |
| 2026-09-23 | 21.85x |
| 2026-09-22 | 22.75x |
| 2026-09-21 | 23.84x |
| 2026-09-18 | 24.59x |
| 2026-09-17 | 24.64x |
| 2026-09-16 | 25.61x |
| 2026-09-15 | 23.99x |
| 2026-09-14 | 23.52x |
| 2026-09-11 | 23.84x |
| 2026-09-10 | 25.08x |
| 2026-09-09 | 25.13x |
| 2026-09-08 | 25.90x |
| 2026-09-04 | 24.76x |
| 2026-09-03 | 24.20x |
| 2026-09-02 | 23.99x |
| 2026-09-01 | 22.97x |
| 2026-08-31 | 22.68x |
| 2026-08-28 | 23.40x |
| 2026-08-27 | 23.52x |
| 2026-08-26 | 23.84x |
| 2026-08-25 | 24.96x |
| 2026-08-24 | 24.03x |
| 2026-08-21 | 24.62x |
| 2026-08-20 | 23.84x |
| 2026-08-19 | 24.37x |
| 2026-08-18 | 22.24x |
| 2026-08-17 | 21.36x |
| 2026-08-14 | 20.71x |
| 2026-08-13 | 21.73x |
| 2026-08-12 | 5.69x |
| 2026-08-11 | 5.52x |
| 2026-08-10 | 5.31x |
| 2026-08-07 | 5.22x |
| 2026-08-06 | 5.10x |
| 2026-08-05 | 5.27x |
| 2026-08-04 | 5.41x |
| 2026-08-03 | 5.28x |
| 2026-07-31 | 5.17x |
| 2026-07-30 | 5.05x |
| 2026-07-29 | 4.98x |
| 2026-07-28 | 4.83x |
| 2026-07-27 | 4.77x |
| 2026-07-24 | 4.88x |
| 2026-07-23 | 5.05x |
| 2026-07-22 | 5.02x |
| 2026-07-21 | 5.33x |
| 2026-07-20 | 5.12x |
| 2026-07-17 | 5.18x |
| 2026-07-16 | 5.38x |
| 2026-07-15 | 5.28x |
| 2026-07-14 | 4.97x |
| 2026-07-13 | 5.35x |
| 2026-07-10 | 6.01x |
| 2026-07-09 | 6.13x |
| 2026-07-08 | 5.95x |
| 2026-07-07 | 6.32x |
| 2026-07-06 | 6.70x |
| 2026-07-02 | 7.16x |
| 2026-07-01 | 6.99x |
| 2026-06-30 | 7.06x |
| 2026-06-29 | 6.87x |
| 2026-06-26 | 6.47x |
| 2026-06-25 | 6.29x |
| 2026-06-24 | 6.49x |
| 2026-06-23 | 6.87x |
| 2026-06-22 | 6.53x |
| 2026-06-18 | 6.20x |
| 2026-06-17 | 5.96x |
| 2026-06-16 | 5.93x |
| 2026-06-15 | 6.14x |
| 2026-06-12 | 6.41x |
| 2026-06-11 | 6.44x |
| 2026-06-10 | 6.07x |
| 2026-06-09 | 6.02x |
| 2026-06-08 | 5.90x |
| 2026-06-05 | 6.11x |
| 2026-06-04 | 6.32x |
| 2026-06-03 | 5.94x |
| 2026-06-02 | 6.10x |
| 2026-06-01 | 6.33x |
| 2026-05-29 | 6.47x |
| 2026-05-28 | 6.93x |
| 2026-05-27 | 6.49x |
| 2026-05-26 | 5.92x |
| 2026-05-22 | 6.04x |
| 2026-05-21 | 5.76x |
| 2026-05-20 | 5.83x |
| 2026-05-19 | 5.80x |
| 2026-05-18 | 5.64x |
| 2026-05-15 | 5.90x |
| 2026-05-14 | 5.91x |
| 2026-05-13 | 6.45x |
| 2026-05-12 | 1.40x |
| 2026-05-11 | 1.29x |
| 2026-05-08 | 1.25x |
| 2026-05-07 | 1.41x |
| 2026-05-06 | 0.91x |
| 2026-05-05 | 0.87x |
| 2026-05-04 | 0.88x |
| 2026-05-01 | 0.88x |
| 2026-04-30 | 0.87x |
| 2026-04-29 | 0.85x |
| 2026-04-28 | 0.87x |
| 2026-04-27 | 0.89x |
| 2026-04-24 | 0.89x |
| 2026-04-23 | 0.88x |
| 2026-04-22 | 0.91x |
| 2026-04-21 | 0.89x |
| 2026-04-20 | 0.89x |
| 2026-04-17 | 0.92x |
| 2026-04-16 | 0.92x |
| 2026-04-15 | 0.92x |
| 2026-04-14 | 0.91x |
| 2026-04-13 | 0.88x |
| 2026-04-10 | 0.86x |
| 2026-04-09 | 0.88x |
| 2026-04-08 | 0.89x |
| 2026-04-07 | 0.86x |
| 2026-04-06 | 0.88x |
| 2026-04-02 | 0.89x |
| 2026-04-01 | 0.91x |
| 2026-03-31 | 0.87x |
| 2026-03-30 | 0.82x |
| 2026-03-27 | 0.85x |
| 2026-03-26 | 0.86x |
| 2026-03-25 | 0.89x |
| 2026-03-24 | 0.89x |
| 2026-03-23 | 0.88x |
| 2026-03-20 | 0.88x |
| 2026-03-19 | 0.91x |
| 2026-03-18 | 0.89x |
| 2026-03-17 | 0.92x |
| 2026-03-16 | 0.87x |
| 2026-03-13 | 0.93x |
| 2026-03-12 | 0.96x |
| 2026-03-11 | 0.90x |
| 2026-03-10 | 0.91x |
| 2026-03-09 | 0.94x |
| 2026-03-06 | 0.81x |
| 2026-03-05 | 0.79x |
| 2026-03-04 | 0.83x |
| 2026-03-03 | 0.83x |
| 2026-03-02 | 0.79x |
| 2026-02-27 | 0.83x |
| 2026-02-26 | 0.82x |
| 2026-02-25 | 0.80x |
| 2026-02-24 | 0.72x |
| 2026-02-23 | 0.72x |
| 2026-02-20 | 0.72x |
| 2026-02-19 | 0.73x |
| 2026-02-18 | 0.74x |
| 2026-02-17 | 0.75x |
| 2026-02-13 | 0.75x |
| 2026-02-12 | 0.75x |
| 2026-02-11 | 0.76x |
| 2026-02-10 | 0.78x |
| 2026-02-09 | 0.79x |
| 2026-02-06 | 0.78x |
| 2026-02-05 | 0.75x |
| 2026-02-04 | 0.78x |
| 2026-02-03 | 0.80x |
| 2026-02-02 | 0.80x |
| 2026-01-30 | 0.81x |
| 2026-01-29 | 0.84x |
| 2026-01-28 | 0.84x |
| 2026-01-27 | 0.84x |
| 2026-01-26 | 0.82x |
| 2026-01-23 | 0.81x |
| 2026-01-22 | 0.79x |
| 2026-01-21 | 0.76x |
| 2026-01-20 | 0.73x |
| 2026-01-16 | 0.75x |
| 2026-01-15 | 0.76x |
| 2026-01-14 | 0.75x |
| 2026-01-13 | 0.74x |
| 2026-01-12 | 0.87x |
| 2026-01-09 | 1.57x |
| 2026-01-08 | 1.90x |
| 2026-01-07 | 1.68x |
| 2026-01-06 | 1.65x |
| 2026-01-05 | 1.85x |
| 2026-01-02 | 1.93x |
| 2025-12-31 | 1.96x |
| 2025-12-30 | 1.94x |
| 2025-12-29 | 1.95x |
| 2025-12-26 | 1.89x |
| 2025-12-24 | 1.92x |
| 2025-12-23 | 1.91x |
| 2025-12-22 | 1.94x |
| 2025-12-19 | 1.88x |
| 2025-12-18 | 1.89x |
| 2025-12-17 | 1.88x |
| 2025-12-16 | 1.92x |
| 2025-12-15 | 1.95x |
| 2025-12-12 | 1.95x |
| 2025-12-11 | 1.94x |
| 2025-12-10 | 1.85x |
| 2025-12-09 | 1.75x |
| 2025-12-08 | 1.69x |
| 2025-12-05 | 1.63x |
| 2025-12-04 | 1.62x |
| 2025-12-03 | 1.47x |
| 2025-12-02 | 1.44x |
| 2025-12-01 | 1.56x |
| 2025-11-28 | 1.70x |
| 2025-11-26 | 1.67x |
| 2025-11-25 | 1.65x |
| 2025-11-24 | 1.60x |
| 2025-11-21 | 1.57x |
| 2025-11-20 | 1.53x |
| 2025-11-19 | 1.57x |
| 2025-11-18 | 1.55x |
| 2025-11-17 | 1.52x |
| 2025-11-14 | 1.58x |
| 2025-11-13 | 1.54x |
| 2025-11-12 | 0.82x |
| 2025-11-11 | 0.82x |
| 2025-11-10 | 0.81x |
| 2025-11-07 | 0.77x |
| 2025-11-06 | 0.78x |
| 2025-11-05 | 0.71x |
| 2025-11-04 | 0.81x |
| 2025-11-03 | 0.91x |
| 2025-10-31 | 0.97x |
| 2025-10-30 | 0.92x |
| 2025-10-29 | 0.92x |
| 2025-10-28 | 1.00x |
| 2025-10-27 | 1.02x |
| 2025-10-24 | 0.95x |
| 2025-10-23 | 0.93x |
| 2025-10-22 | 0.96x |
| 2025-10-21 | 1.03x |
| 2025-10-20 | 1.05x |
| 2025-10-17 | 0.97x |
| 2025-10-16 | 1.00x |
| 2025-10-15 | 1.00x |
| 2025-10-14 | 0.96x |
| 2025-10-13 | 0.99x |
| 2025-10-10 | 0.94x |
| 2025-10-09 | 1.05x |
| 2025-10-08 | 1.04x |
| 2025-10-07 | 1.02x |
| 2025-10-06 | 0.92x |
| 2025-10-03 | 0.94x |
| 2025-10-02 | 0.95x |
| 2025-10-01 | 0.95x |
| 2025-09-30 | 0.94x |
| 2025-09-29 | 0.91x |
| 2025-09-26 | 0.90x |
| 2025-09-25 | 0.91x |
| 2025-09-24 | 0.93x |
| 2025-09-23 | 0.85x |
Showing the most recent 260 of 1,361 data points. The chart above shows the full history.
